Teva Pharmaceutical Indus Stock (NYSE: TEVA) stock price, news, charts, stock research, profile.
You can purchase shares of Teva Pharmaceutical Indus (NYSE:TEVA) through any online brokerage.
Other companies in Teva Pharmaceutical Indus’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
Teva Pharmaceutical Indus has a consensus price target of $17.70.
The stock price for Teva Pharmaceutical Indus (NYSE: TEVA) is $16.695 last updated November 14, 2024 at 12:07 PM EST.
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on December 12, 2017 to stockholders of record on November 28, 2017.
Teva Pharmaceutical Indus’s Q4 earnings are confirmed for Wednesday, January 29, 2025.
There is no upcoming split for Teva Pharmaceutical Indus.
Teva Pharmaceutical Indus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.